---
figid: PMC6024333__10.1177_1758835918777427-fig2
figlink: /pmc/articles/PMC6024333/figure/fig2-1758835918777427/
number: Figure 2
caption: Schematic representation of mechanisms of innate and acquired resistance
  to immune-checkpoint inhibitors (ICPIs). Interferon (IFN)-γ signals via the type
  2 IFN (IFN-2) receptor which relies on Janus kinase 1/2 (JAK1/2) phosphorylation
  to initiate signal transducer and activator of transcription (STAT) dimerization
  and transcriptional alterations on nuclear translocation. Similarly WNT phosphorylation
  cascades initiate alterations in β-catenin signalling. Alterations in this pathway
  or mutations in JAK1/2 lead to transcriptional modification of proteins which may
  result in, for example, impaired major histocompatibility complex (MHC) class I
  folding, or programmed cell death protein 1 ligand 1 (PD-L1) upregulation. Alternatively,
  epigenetic modification may alter regulatory protein function. Impaired MHC class
  I folding impairs T-cell receptor (TCR) recognition of mutation-associated neoantigens
  (MANAs) or fewer tumour mutations and their associated MANAs or less heterogeneity,
  a greater degree of which would normally induce cytotoxic T-cell binding, and the
  initiation of an effective antitumour response. In addition, an increased infiltration
  of regulatory T-cell (T-reg) and anti-inflammatory tumour-associated macrophages
  (TAMs) within the tumour microenvironment (TME) limit the induction of an adequate
  immune response.
pmcid: PMC6024333
papertitle: 'Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing
  to rational selection.'
reftext: Michael Flynn, et al. Ther Adv Med Oncol. 2018;10:1758835918777427.
pmc_ranked_result_index: '21665'
pathway_score: 0.7812348
filename: 10.1177_1758835918777427-fig2.jpg
figtitle: Mechanisms of innate and acquired resistance to immune-checkpoint inhibitors
  (ICPIs)
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6024333__10.1177_1758835918777427-fig2.html
  '@type': Dataset
  description: Schematic representation of mechanisms of innate and acquired resistance
    to immune-checkpoint inhibitors (ICPIs). Interferon (IFN)-γ signals via the type
    2 IFN (IFN-2) receptor which relies on Janus kinase 1/2 (JAK1/2) phosphorylation
    to initiate signal transducer and activator of transcription (STAT) dimerization
    and transcriptional alterations on nuclear translocation. Similarly WNT phosphorylation
    cascades initiate alterations in β-catenin signalling. Alterations in this pathway
    or mutations in JAK1/2 lead to transcriptional modification of proteins which
    may result in, for example, impaired major histocompatibility complex (MHC) class
    I folding, or programmed cell death protein 1 ligand 1 (PD-L1) upregulation. Alternatively,
    epigenetic modification may alter regulatory protein function. Impaired MHC class
    I folding impairs T-cell receptor (TCR) recognition of mutation-associated neoantigens
    (MANAs) or fewer tumour mutations and their associated MANAs or less heterogeneity,
    a greater degree of which would normally induce cytotoxic T-cell binding, and
    the initiation of an effective antitumour response. In addition, an increased
    infiltration of regulatory T-cell (T-reg) and anti-inflammatory tumour-associated
    macrophages (TAMs) within the tumour microenvironment (TME) limit the induction
    of an adequate immune response.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT10A
  - WNT9B
  - WNT5B
  - STAT3
  - STAT1
  - WNT6
  - STAT2
  - WNT11
  - CTNNB1
  - WNT9A
  - TRG
  - JAK1
  - WNT2B
  - STAT6
  - STAT5B
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT10B
  - TRD
  - TRA
  - TRB
  - WNT5A
  - WNT16
  - WNT3A
  - CD274
  - STAT4
  - WNT3
  - WNT2
  - JAK2
  - WNT4
  - STAT5A
  - WNT1
  - TAM
  - TCR
  - Cytotoxic T
genes:
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: WNT
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
chemicals:
- word: TAM
  source: MESH
  identifier: C419191
- word: TCR
  source: MESH
  identifier: D017260
diseases:
- word: Cytotoxic T
  source: MESH
  identifier: D064420
---
